(Circulation. 1995;91:1229-1235.)
© 1995 American Heart Association, Inc.
Articles |
From the Second Department of Internal Medicine (Y.H., H.H., E.S., K. Kimura, M.O.) and Faculty of Pharmaceutical Sciences (K. Kikuchi, T.N., M.H.), University of Tokyo, Japan.
Correspondence to Yasunobu Hirata, MD, the Second Department of Internal Medicine, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113, Japan.
Background Stimulation of endothelin subtype B (ETB) receptors has been proposed to induce release of endothelium-derived nitric oxide (EDNO).
Methods and Results To obtain direct evidence of its release and its alteration in deoxycorticosterone acetate (DOCA)-salt hypertension, EDNO released from renal vessels by ET stimulation was assayed by a highly sensitive chemiluminescence method. Kidneys were isolated from DOCA-salt and control rats, and renal perfusion pressure (RPP) and EDNO (by hydrogen peroxideluminol chemiluminescence) in the perfusate were monitored simultaneously during perfusion of ET-1, ET-3, an ETA receptor antagonist (BQ-123), and an ETB receptor agonist (BQ-3020). In control rats, ET-1 and ET-3 dose-dependently increased both RPP and NO release. Although the vasoconstricting effects of ET-1 were greater, their NO-releasing effects were comparable. The increase in NO release by ETs was inhibited by NG-monomethyl-L-arginine. After 10-6 mol/L BQ-123 treatment, ET-1 decreased RPP and increased NO release in control kidneys. DOCA-salt rats responded to these agents with much less NO release. BQ-3020 at up to 10-10 mol/L caused vasodilation (RPP, 10-11 mol/L, -5.4±1.7%, P<.01) associated with increased NO release in control kidneys (+9.0±2.7 fmol · min-1 · g-1 kidney wt, P<.01). However, in DOCA-salt kidneys, BQ-3020 caused renal vasoconstriction (RPP, +5.4±2.4%, P<.01 versus control) and a much smaller NO release (+1.1±0.4 fmol · min-1 · g-1 kidney wt, P<.01 versus control). Northern blot analysis revealed that renal ETB mRNA was significantly decreased in DOCA-salt rat kidneys compared with controls (0.36±0.13 versus 1.00±0.23, P<.05).
Conclusions These results suggest that ET-1 and ET-3 release EDNO via ETB receptors in renal vessels. ETB-mediated NO release was reduced in DOCA-salt rats, which may modulate renal function and thus blood pressure regulation in DOCA-salt hypertensive rats.
Key Words: endothelium-derived factors endothelin hypertension kidney
This article has been cited by other articles:
![]() |
T. L. Thai and W. J. Arendshorst ADP-ribosyl cyclase and ryanodine receptors mediate endothelin ETA and ETB receptor-induced renal vasoconstriction in vivo Am J Physiol Renal Physiol, August 1, 2008; 295(2): F360 - F368. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Schneider, E. W. Inscho, and D. M. Pollock Attenuated vasoconstrictor responses to endothelin in afferent arterioles during a high-salt diet Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1208 - F1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jesmin, S. Zaedi, S. Maeda, I. Yamaguchi, K. Goto, and T. Miyauchi Effects of a Selective Endothelin A Receptor Antagonist on the Expressions of iNOS and eNOS in the Heart of Early Streptozotocin-Induced Diabetic Rats. Experimental Biology and Medicine, June 1, 2006; 231(6): 925 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Herrera, P. A. Ortiz, and J. L. Garvin Regulation of thick ascending limb transport: role of nitric oxide Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1279 - F1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Vargas, J. M. Moreno, I. Rodriguez-Gomez, R. Wangensteen, A. Osuna, M. Alvarez-Guerra, and J. Garcia-Estan Vascular and renal function in experimental thyroid disorders Eur. J. Endocrinol., February 1, 2006; 154(2): 197 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Takeda, H. Nishimatsu, E. Suzuki, H. Satonaka, D. Nagata, S. Oba, M. Sata, M. Takahashi, Y. Yamamoto, Y. Terauchi, et al. Ghrelin Improves Renal Function in Mice with Ischemic Acute Renal Failure J. Am. Soc. Nephrol., January 1, 2006; 17(1): 113 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Just, A. J. M. Olson, J. R. Falck, and W. J. Arendshorst NO and NO-independent mechanisms mediate ETB receptor buffering of ET-1-induced renal vasoconstriction in the rat Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1168 - R1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Conrad Mechanisms of Renal Vasodilation and Hyperfiltration During Pregnancy Reproductive Sciences, October 1, 2004; 11(7): 438 - 448. [Abstract] [PDF] |
||||
![]() |
K. P. Conrad and J. Novak Emerging role of relaxin in renal and cardiovascular function Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R250 - R261. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liu, R. T. Premont, C. D. Kontos, J. Huang, and D. C. Rockey Endothelin-1 Activates Endothelial Cell Nitric-oxide Synthase via Heterotrimeric G-protein {beta}{gamma} Subunit Signaling to Protein Kinase B/Akt J. Biol. Chem., December 12, 2003; 278(50): 49929 - 49935. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nishimatsu, Y. Hirata, T. Shindo, H. Kurihara, M. Kakoki, D. Nagata, H. Hayakawa, H. Satonaka, M. Sata, A. Tojo, et al. Role of Endogenous Adrenomedullin in the Regulation of Vascular Tone and Ischemic Renal Injury: Studies on Transgenic/Knockout Mice of Adrenomedullin Gene Circ. Res., April 5, 2002; 90(6): 657 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Notenboom, D. S. Miller, P. Smits, F. G. M. Russel, and R. Masereeuw Role of NO in endothelin-regulated drug transport in the renal proximal tubule Am J Physiol Renal Physiol, March 1, 2002; 282(3): F458 - F464. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mori, G. L. King, A. C. Clermont, D. K. Bursell, and S.-E. Bursell Endothelin-3 Regulation of Retinal Hemodynamics in Nondiabetic and Diabetic Rats Invest. Ophthalmol. Vis. Sci., November 1, 2000; 41(12): 3955 - 3962. [Abstract] [Full Text] |
||||
![]() |
C. F. Plato, D. M. Pollock, and J. L. Garvin Endothelin inhibits thick ascending limb chloride flux via ETB receptor-mediated NO release Am J Physiol Renal Physiol, August 1, 2000; 279(2): F326 - F333. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. KAKOKI, Y. HIRATA, H. HAYAKAWA, E. SUZUKI, D. NAGATA, A. TOJO, H. NISHIMATSU, N. NAKANISHI, Y. HATTORI, K. KIKUCHI, et al. Effects of Tetrahydrobiopterin on Endothelial Dysfunction in Rats with Ischemic Acute Renal Failure J. Am. Soc. Nephrol., February 1, 2000; 11(2): 301 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Berthold, A. Just, H. R. Kirchheim, and H. Ehmke Interaction Between Nitric Oxide and Endogenous Vasoconstrictors in Control of Renal Blood Flow Hypertension, December 1, 1999; 34(6): 1254 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhang, B. Luo, S.-J. Chen, G. A. Abrams, and M. B. Fallon Endothelin-1 stimulation of endothelial nitric oxide synthase in the pathogenesis of hepatopulmonary syndrome Am J Physiol Gastrointest Liver Physiol, November 1, 1999; 277(5): G944 - G952. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. ALLCOCK, M. HUKKANEN, J. M. POLAK, J. S. POLLOCK, and D. M. POLLOCK Increased Nitric Oxide Synthase-3 Expression in Kidneys of Deoxycorticosterone Acetate-Salt Hypertensive Rats J. Am. Soc. Nephrol., November 1, 1999; 10(11): 2283 - 2289. [Abstract] [Full Text] |
||||
![]() |
V. GROSS, W. SCHNEIDER, W.-H. SCHUNCK, E. MERVAALA, and F. C. LUFT Chronic Effects of Lovastatin and Bezafibrate on Cortical and Medullary Hemodynamics in Deoxycorticosterone Acetate-Salt Hypertensive Mice J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1430 - 1439. [Abstract] [Full Text] |
||||
![]() |
F. RUSCHITZKA, S. SHAW, D. GYGI, G. NOLL, M. BARTON, and T. F. LÜSCHER Endothelial Dysfunction in Acute Renal Failure: Role of Circulatingand Tissue Endothelin-1 J. Am. Soc. Nephrol., May 1, 1999; 10(5): 953 - 962. [Abstract] [Full Text] |
||||
![]() |
K. P. Conrad, R. E. Gandley, T. Ogawa, S. Nakanishi, and L. A. Danielson Endothelin mediates renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats Am J Physiol Renal Physiol, May 1, 1999; 276(5): F767 - F776. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kakoki, Y. Hirata, H. Hayakawa, A. Tojo, D. Nagata, E. Suzuki, K. Kimura, A. Goto, K. Kikuchi, T. Nagano, et al. Effects of Hypertension, Diabetes Mellitus, and Hypercholesterolemia on Endothelin Type B Receptor–Mediated Nitric Oxide Release From Rat Kidney Circulation, March 9, 1999; 99(9): 1242 - 1248. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hayakawa, Y. Hirata, M. Kakoki, Y. Suzuki, H. Nishimatsu, D. Nagata, E. Suzuki, K. Kikuchi, T. Nagano, K. Kangawa, et al. Role of Nitric Oxide–cGMP Pathway in Adrenomedullin-Induced Vasodilation in the Rat Hypertension, February 1, 1999; 33(2): 689 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kakoki, Y. Hirata, H. Hayakawa, H. Nishimatsu, Y. Suzuki, D. Nagata, E. Suzuki, K. Kikuchi, T. Nagano, and M. Omata Effects of Vasodilatory ß-Adrenoceptor Antagonists on Endothelium-Derived Nitric Oxide Release in Rat Kidney Hypertension, January 1, 1999; 33(1): 467 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zuckerman, P. N. Chander, G. A. Zeballos, and C. T. Stier Jr Regional Renal Nitric Oxide Release in Stroke-Prone Spontaneously Hypertensive Rats Hypertension, December 1, 1997; 30(6): 1479 - 1486. [Abstract] [Full Text] |
||||
![]() |
Y. Hirata, H. Hayakawa, M. Kakoki, A. Tojo, E. Suzuki, D. Nagata, K. Kimura, A. Goto, K. Kikuchi, T. Nagano, et al. Receptor Subtype for Vasopressin-Induced Release of Nitric Oxide From Rat Kidney Hypertension, January 1, 1997; 29(1): 58 - 64. [Abstract] [Full Text] |
||||
![]() |
Y. Hirata, H. Hayakawa, M. Kakoki, A. Tojo, E. Suzuki, K. Kimura, A. Goto, K. Kikuchi, T. Nagano, M. Hirobe, et al. Nitric Oxide Release From Kidneys of Hypertensive Rats Treated With Imidapril Hypertension, March 1, 1996; 27(3): 672 - 678. [Abstract] [Full Text] |
||||
![]() |
H. Nishimatsu, Y. Hirata, T. Shindo, H. Kurihara, M. Kakoki, D. Nagata, H. Hayakawa, H. Satonaka, M. Sata, A. Tojo, et al. Role of Endogenous Adrenomedullin in the Regulation of Vascular Tone and Ischemic Renal Injury: Studies on Transgenic/Knockout Mice of Adrenomedullin Gene Circ. Res., April 5, 2002; 90(6): 657 - 663. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |